Literature DB >> 9751117

Differential apoptotic behaviors of c-myc, N-myc, and L-myc oncoproteins.

C E Nesbit1, L E Grove, X Yin, E V Prochownik.   

Abstract

c-, N-, and L-myc are related nuclear oncoproteins that bind similar DNA sites and cooperate with activated ras oncogenes to transform primary fibroblasts. Although c-myc can also promote apoptosis in some cells after growth factor withdrawal or exposure to cytotoxic agents, roles for N- and L-myc in apoptosis remain undetermined. To address this, c-, N-, or L-myc were stably expressed in the interleukin 3 (IL-3)-dependent 32D hematopoietic cell line. The apoptotic response of each cell line was assessed after IL-3 withdrawal or treatment with four structurally unrelated cytotoxic agents. All three oncoproteins accelerated apoptosis after IL-3 withdrawal. In contrast, whereas c-myc overexpression generally sensitized cells to cytotoxic drugs, N-myc and L-myc overexpression produced resistance. myc expression tended to be associated with a more robust G2-M arrest after drug exposure, but this did not correlate with drug sensitivity or resistance. Bcl-2 and Bcl-X(L) protected control cells against apoptosis after either IL-3 withdrawal or drug exposure, although in some cases this effect could be overridden by myc oncoproteins, particularly N-myc and L-myc. Our results suggest that the apoptotic pathways activated upon IL-3 withdrawal and cytotoxic drug treatment are distinct and differentially affected by members of the myc and Bcl-2 families.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9751117

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  16 in total

1.  Sequence signatures and the probabilistic identification of proteins in the Myc-Max-Mad network.

Authors:  William R Atchley; Andrew D Fernandes
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-25       Impact factor: 11.205

2.  Pleiotropic role for MYCN in medulloblastoma.

Authors:  Fredrik J Swartling; Matthew R Grimmer; Christopher S Hackett; Paul A Northcott; Qi-Wen Fan; David D Goldenberg; Jasmine Lau; Selma Masic; Kim Nguyen; Slava Yakovenko; Xiao-Ning Zhe; Heather C Flynn Gilmer; Rodney Collins; Mai Nagaoka; Joanna J Phillips; Robert B Jenkins; Tarik Tihan; Scott R Vandenberg; C David James; Kohichi Tanaka; Michael D Taylor; William A Weiss; Louis Chesler
Journal:  Genes Dev       Date:  2010-05-15       Impact factor: 11.361

Review 3.  Family matters: How MYC family oncogenes impact small cell lung cancer.

Authors:  Johannes Brägelmann; Stefanie Böhm; Matthew R Guthrie; Gurkan Mollaoglu; Trudy G Oliver; Martin L Sos
Journal:  Cell Cycle       Date:  2017-07-24       Impact factor: 4.534

Review 4.  Cellular senescence in neuroblastoma.

Authors:  Sofia Zanotti; Bieke Decaesteker; Suzanne Vanhauwaert; Bram De Wilde; Winnok H De Vos; Frank Speleman
Journal:  Br J Cancer       Date:  2022-02-23       Impact factor: 9.075

5.  Chromosomal location targets different MYC family gene members for oncogenic translocations.

Authors:  Monica Gostissa; Sheila Ranganath; Julia M Bianco; Frederick W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-27       Impact factor: 11.205

6.  Discovery of novel Myc-Max heterodimer disruptors with a three-dimensional pharmacophore model.

Authors:  Gabriela Mustata; Ariele Viacava Follis; Dalia I Hammoudeh; Steven J Metallo; Huabo Wang; Edward V Prochownik; John S Lazo; Ivet Bahar
Journal:  J Med Chem       Date:  2009-03-12       Impact factor: 7.446

Review 7.  BAR the door: cancer suppression by amphiphysin-like genes.

Authors:  George C Prendergast; Alexander J Muller; Arivudanambi Ramalingam; Mee Young Chang
Journal:  Biochim Biophys Acta       Date:  2008-09-18

8.  Glutathione depletion induced by c-Myc downregulation triggers apoptosis on treatment with alkylating agents.

Authors:  Annamaria Biroccio; Barbara Benassi; Francesco Fiorentino; Gabriella Zupi
Journal:  Neoplasia       Date:  2004 May-Jun       Impact factor: 5.715

Review 9.  Reconciling the Biological and Transcriptional Variability of Hepatoblastoma with Its Mutational Uniformity.

Authors:  Edward V Prochownik
Journal:  Cancers (Basel)       Date:  2021-04-21       Impact factor: 6.639

10.  Identification of cytotoxic drugs that selectively target tumor cells with MYC overexpression.

Authors:  Anna Frenzel; Hanna Zirath; Marina Vita; Ami Albihn; Marie Arsenian Henriksson
Journal:  PLoS One       Date:  2011-11-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.